Whales with a lot of money to spend have taken a noticeably bearish stance on AbbVie.
Looking at options history for AbbVie ABBV we detected 15 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 40% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $199,317 and 13, calls, for a total amount of $651,450.
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $165.0 to $210.0 for AbbVie during the past quarter.
Volume & Open Interest Trends
In today's trading context, the average open interest for options of AbbVie stands at 941.86, with a total volume reaching 2,530.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in AbbVie, situated within the strike price corridor from $165.0 to $210.0, throughout the last 30 days.
AbbVie 30-Day Option Volume & Interest Snapshot
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | PUT | SWEEP | BULLISH | 03/21/25 | $12.2 | $12.0 | $11.98 | $195.00 | $150.3K | 559 | 291 |
| ABBV | CALL | SWEEP | BULLISH | 03/21/25 | $9.2 | $9.15 | $9.18 | $200.00 | $108.8K | 1.5K | 237 |
| ABBV | CALL | SWEEP | BULLISH | 12/20/24 | $2.73 | $2.7 | $2.73 | $210.00 | $96.7K | 354 | 377 |
| ABBV | CALL | SWEEP | BULLISH | 11/15/24 | $13.1 | $12.95 | $13.06 | $185.00 | $84.7K | 3.1K | 70 |
| ABBV | CALL | SWEEP | BEARISH | 11/15/24 | $25.9 | $25.5 | $25.5 | $170.00 | $66.3K | 550 | 36 |
About AbbVie
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
Where Is AbbVie Standing Right Now?
- With a trading volume of 1,696,972, the price of ABBV is down by -0.11%, reaching $193.61.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 31 days from now.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for AbbVie with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
